
TCB-32 (Compound I-1) is a FGFR1 агонист with an EC50 of 0.88 μM. TCB-32 significantly increases клетка proliferation through activating FGFR1 signaling pathway as bFGF and its downstream ERK 1/2 with excellent thermal stability. TCB-32 can replace bFGF in serum-free клетка culture media. TCB-32 can be used for tissue repair and wound healing related diseases like psoriasis and eczema research.
TCB-32 (Compound I-1) is a FGFR1 agonist with an EC50 of 0.88 μM. TCB-32 significantly increases cell proliferation through activating FGFR1 signaling pathway as bFGF and its downstream ERK 1/2 with excellent thermal stability. TCB-32 can replace bFGF in serum-free cell culture media. TCB-32 can be used for tissue repair and wound healing related diseases like psoriasis and eczema research.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.